News

The pharmaceutical lobbying group's aura of invincibility has faded. The U.S. Senate recently passed a new bill, leaving the pharmaceutical sector licking its wounds and paving the way for a significant drug pricing overhaul. If the comprehensive climate and tax...

There were a lot of mysteries surrounding COVID-19, some of which have been answered, but many more have not. Since the start of the pandemic, it has been a mystery as to why children appear to be considerably less...

As competing businesses rushed to deliver the first COVID-19 vaccine starting in early 2020, the pharmaceutical sector has been in the press more than ever. However, they are now focusing on the second emergency that we all face: the...

The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger RNA (mRNA) vaccines. The first job for the newly formed Working Party will be to produce...

Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA). Influenza pandemics, which are caused...

A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA). The new strategy, according to EMA, will...

Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10% increase by year's end. Pharma exports to the European Union and other CIS countries, which were affected...